UHN COMBIEL

Address

Research at Princess Margaret Hospital
University Health Network
610 University Ave
Toronto, M5A 3W7
Canada

Follow

2015

CANADIAN FAMILY MEDICINE CONFERENCE: FAMILY MEDICINE FORUM

Toronto, ON, November 2015

Name: Trevor Morey

Presentation Type: Poster

Title: Hesitancy of transitioning care of cancer survivors from the oncologist to the family physician

INTERNATIONAL SOCIETY FOR PHARMACOGENOMICS AND OUTCOMES RESEARCH

Milan, Italy, November 2015

Name: Zahra Merali
Presentation Type: Poster
Title: Barriers to using computer-assisted technology (CAT) in cancer patient reported outcome surveys (PROs) of treatment toxicities 

Name: Valerie Ho

Presentation Type: Poster

Title: The willingness of cancer outpatients to complete patient-reported outcome measures outside of the clinic. 

THE CANADIAN SOCIETY OF EPIDEMIOLOGY AND BIOSTATISTICS CONFERENCE

Mississauga, ON, June 2015

Name: Samantha Sarabia

Presentation Type: Poster

Title: Are Palliative Patients Less Accepting to Self-Report Symptom Measures For Clinical Management than Curative Patients?

 

Name:  Sabrina Yeung

Presentation Type: Poster

Title: Comparison of prevalence of pain symptoms and completion rates using a patient-reported outcomes (PRO) tool of pain in palliative and curative patients.

THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY: EUROPEAN CANCER CONFERENCE

Vienna, Austria, September 2015

Name: Zahra Merali

Presentation Type: Poster

Title: Barriers to using computer-assisted technology (CAT) in patient reported outcome symptom surveys for routine supportive care

IASLC, 17TH WORLD CONFERENCE ON LUNG CANCER

Denver, CO, September 2015

Name: Catherine Labbe

Presentation Type: Poster

Title: Health Utility and Global Quality of Life Scores in Patients with Metastatic Lung Cancer by EGFR and ALK studies

THE 31ST INTERNATIONAL CONFERENCE ON PHARMACOEPIDEMIOLOGY & THERAPEUTIC RISK MANAGEMENT 

Boston, MA, August 2015

Name: Erin Stewart

Presentation Type: Poster

Title: PAtient-reported health utility scores (HUS) in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations by drug therapy.

 

Name: Tian Wang

Presentation Type: Poster

Title: Active Surveillance of skin toxicities through web-based patient-reported (PRO) toxicity reporting tool in outpatient cancer patients on EGFR tyrosine kinase inhibitors (TKI): A feasibility study

 

Name: Joesph Samuel

Presentation Type: Poster

Title: Pharmacovigilance data from systematic patient reported outcome (PRO) tools versus usual clinician interactions: Are cancer patients reporting toxicity data to their health care providers?

Name: Lawson Eng

Presentation Type: Poster

Title: Access to Drug Benefit Plans Among Canadian Cancer Survivors

THE CANADIAN SOCIETY OF EPIDEMIOLOGY AND BIOSTATISTICS CONFERENCE

Mississauga, ON, June 2015

Name: Erin Stewart

Presentation Type: Poster

Title: The application of Canadian patient-reported health utility scores (HUS) derived from the EQ5D-3L questionnaire for metastatic non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations.

ASCO ANNUAL MEETING

Chicago, IL, May 2015

Name: Hiten Naik

Presentation Type: Poster

Title: Stage specific health utility index scores of Canadian cancer patients.

 

Name: Lawson Eng

Presentation Type: Poster

Title: Cancer patients' attitudes, knowledge, and preferences for smoking cessation (SC).

 

Name: Lawson Eng

Presentation Type: Poster

Title: Change in second-hand smoke exposure after a lung and head and neck cancer diagnosis and subsequent patient smoking cessation.

 

Name: Geoffrey Liu

Presentation Type: Poster

Title: Prediction models of smoking cessation in lung and head and neck cancer patients: Role of second-hand smoke (SHS) exposure.

 

Name: Mark Doherty

Presentation Type: Poster

Title: Patient-reported symptoms and Canadian Health Utility scores in esophageal cancer patients

EUROPEAN LUNG CANCER CONFERENCE

Geneva, Switzerland, April 2015

Name: Erin Stewart

Presentation Type: Poster

Title: Development of resistance models to tyrosine kianse inhibitors (TKIs) in patient-derived xenograft models (PDXs) of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations.

ASCO GASTROINTESTINAL CANCERS SYMPOSIUM

San Francisco, CA, January 2015

Name: Mark Doherty
Presentation Type: Poster
Title: The Relationship between Health Utility, Quality of Life, and Symptom Scores in Canadian Patients with Esophageal Cancer

Name: Anita Choudhary

Presentation Type: Poster

Title: Quality of Life (QOL) in Esophageal Cancer Patients treated with Radiation (RT) in the Radical Setting